hypertension Archives -

blood_pressure_cuff_mockup_graphics_unsplash

Hundreds of thousands of people in Great Britain have missed out on receiving medication that could protect them

Unmedicated nation: COVID cuts heart drug use in GB

https://pharmaphorum.com/news/unmedicated-nation-covid-cuts-heart-drug-use-in-gb/

AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AstraZeneca bolts on blood pressure drug with CinCor takeover

Phil Taylor AstraZeneca, cardiovascular, chronic kidney disease, CinCor Pharma, Farxiga, hypertension, M&A, nephrology 0 Comment

AstraZeneca has extended its cardiorenal pipeline with a $1.3 billion acquisition of CinCor Pharma, adding a late-stage blood

AstraZeneca bolts on blood pressure drug with CinCor takeover

https://pharmaphorum.com/news/astrazeneca-bolts-on-blood-pressure-drug-with-cincor-takeover/

Market Access/ News/ News

Idorsia files resistant hypertension drug aprocitentan in US

Phil Taylor aprocitentan, cardiovascular disease, hypertension, Idorsia, Johnson & Johnson, regulatory 0 Comment

Switzerland’s Idorsia has submitted a new drug application to the FDA for aprocitentan as a treatment for people

Idorsia files resistant hypertension drug aprocitentan in US

https://pharmaphorum.com/news/idorsia-files-resistant-hypertension-drug-aprocitentan-in-us/

News/ News/ R&D

J&J, Idorsia plan filings for aprocitentan data in resistant hypertension

Phil Taylor aprocitentan, cardiovascular disease, hypertension, Idorsia, Janssen, Johnson & Johnson 0 Comment

People whose blood pressure remains stubbornly high despite current drug treatment and are at increased risk of complications

J&J, Idorsia plan filings for aprocitentan data in resistant hypertension

https://pharmaphorum.com/news/jj-idorsia-plan-filings-for-aprocitentan-data-in-resistant-hypertension/

Digital/ News/ News

George taps Medisante tech for decentralised blood pressure trial

Phil Taylor decentralised clinical trials, digital, digital health, George Medicines, hypertension, Medisante 0 Comment

George Medicines has partnered with Medisante to provide technology for a study of an experimental triple therapy for

George taps Medisante tech for decentralised blood pressure trial

https://pharmaphorum.com/news/george-taps-medisante-tech-for-decentralised-blood-pressure-trial/

Market Access/ News/ News

MHRA gives Alnylam ‘innovation passport’ for hypertension drug zilebesiran

Phil Taylor Alnylam, HEOR, hypertension, innovation passport, MHRA, NHS, regulatory, UK, zilebesiran 0 Comment

The UK medicines regulator has awarded Alnylam’s RNAi-based therapy zilebesiran for hypertension an ‘innovation passport‘, a designation designed

MHRA gives Alnylam ‘innovation passport’ for hypertension drug zilebesiran

https://pharmaphorum.com/news/mhra-gives-alnylam-innovation-passport-for-hypertension-drug-zilebesiran/

Digital/ News/ News

CLM tests drug plus digital combo for high blood pressure

Phil Taylor app, Closed Loop Medicine, digital, hypertension 0 Comment

UK biotech Closed Loop Medicine (CLM) has started recruiting patients into a trial that will test whether a

CLM tests drug plus digital combo for high blood pressure

https://pharmaphorum.com/news/clm-tests-drug-plus-digital-combo-for-high-blood-pressure/

News

Celltrion buys drug portfolio from Takeda, ventures into chronic diseases

Richard Staines Celltrion, chronic diseases, Diabetes, hypertension, M&A, Takeda 0 Comment

South Korea’s Celltrion has made its first major acquisition, buying a portfolio of drugs including diabetes and hypertension drugs from

Celltrion buys drug portfolio from Takeda, ventures into chronic diseases

https://pharmaphorum.com/news/celltrion-ventures-into-chronic-diseases-with-takeda-portfolio-buy/

Market Access/ News/ News

AZ picks up $350m after selling hypertension drugs

Richard Staines AstraZeneca, Bayer, cancer, cardiology, GW Pharma, hypertension, multiple sclerosis 0 Comment

AstraZeneca has picked up a $350m windfall after selling off five hypertension medicines to generics specialist Atnahs Pharma.

AZ picks up $350m after selling hypertension drugs

https://pharmaphorum.com/news/az-picks-up-350m-after-selling-hypertension-drugs/

Trending

hypertension

Login